245 related articles for article (PubMed ID: 21521867)
1. Role of α2-agonists in the treatment of acute alcohol withdrawal.
Muzyk AJ; Fowler JA; Norwood DK; Chilipko A
Ann Pharmacother; 2011 May; 45(5):649-57. PubMed ID: 21521867
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine: pediatric pharmacology, clinical uses and safety.
Su F; Hammer GB
Expert Opin Drug Saf; 2011 Jan; 10(1):55-66. PubMed ID: 20718689
[TBL] [Abstract][Full Text] [Related]
3. Alpha-2 Agonists.
Nguyen V; Tiemann D; Park E; Salehi A
Anesthesiol Clin; 2017 Jun; 35(2):233-245. PubMed ID: 28526145
[TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of Partial α2 -Adrenoceptor Agonist and Pure α2 -Adrenoceptor Antagonist on the Behavioural Symptoms of Withdrawal after Chronic Alcohol Administration in Mice.
Arora S; Vohora D
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):202-9. PubMed ID: 26867012
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine: new insights.
Mantz J; Josserand J; Hamada S
Eur J Anaesthesiol; 2011 Jan; 28(1):3-6. PubMed ID: 20881501
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine for acute baclofen withdrawal.
Morr S; Heard CM; Li V; Reynolds RM
Neurocrit Care; 2015 Apr; 22(2):288-92. PubMed ID: 25403764
[TBL] [Abstract][Full Text] [Related]
7. α2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells.
Park JW; Chung HW; Lee EJ; Jung KH; Paik JY; Lee KH
Neurosci Lett; 2013 Apr; 541():184-9. PubMed ID: 23485735
[TBL] [Abstract][Full Text] [Related]
8. [Dexmedetomidine improves alcohol withdrawal symptom via activating α
Zeng T; Zhang HY; Zhao X; Liu Y; Guan YZ
Sheng Li Xue Bao; 2022 Aug; 74(4):541-547. PubMed ID: 35993205
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research.
Muzyk AJ; Kerns S; Brudney S; Gagliardi JP
CNS Drugs; 2013 Nov; 27(11):913-20. PubMed ID: 23975661
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology corner.
Rundio AA
J Addict Nurs; 2013; 24(2):122. PubMed ID: 24621491
[No Abstract] [Full Text] [Related]
11. Dexmedetomidine and clonidine induce long-lasting activation of the respiratory rhythm generator of neonatal mice: possible implication for critical care.
Voituron N; Hilaire G; Quintin L
Respir Physiol Neurobiol; 2012 Jan; 180(1):132-40. PubMed ID: 22108092
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting?
Pichot C; Ghignone M; Quintin L
J Intensive Care Med; 2012; 27(4):219-37. PubMed ID: 21525113
[TBL] [Abstract][Full Text] [Related]
13. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.
Honey BL; Benefield RJ; Miller JL; Johnson PN
Ann Pharmacother; 2009 Sep; 43(9):1506-11. PubMed ID: 19690220
[TBL] [Abstract][Full Text] [Related]
14. [α2-Agonists during withdrawal].
Tonner PH; Paris A
Pharm Unserer Zeit; 2011 Nov; 40(6):481-2. PubMed ID: 22028132
[No Abstract] [Full Text] [Related]
15. [Dexmedetomidine and clonidine: a review of their pharmacodynamy to define their role for sedation in intensive care patients].
Pichot C; Longrois D; Ghignone M; Quintin L
Ann Fr Anesth Reanim; 2012 Nov; 31(11):876-96. PubMed ID: 23089375
[TBL] [Abstract][Full Text] [Related]
16. Clonidine in paediatric anaesthesia.
Jöhr M
Eur J Anaesthesiol; 2011 May; 28(5):325-6. PubMed ID: 21487263
[No Abstract] [Full Text] [Related]
17. Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.
Baumann MH; Milchanowski AB; Rothman RB
Neuroscience; 2004; 125(3):683-90. PubMed ID: 15099682
[TBL] [Abstract][Full Text] [Related]
18. Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?
Albertson TE; Chenoweth J; Ford J; Owen K; Sutter ME
J Med Toxicol; 2014 Dec; 10(4):369-81. PubMed ID: 25238670
[TBL] [Abstract][Full Text] [Related]
19. [Use of clonidine in the prevention of alcohol withdrawal syndrome].
Mondavio M; Ghiazza GF
Minerva Med; 1989 Nov; 80(11):1233-5. PubMed ID: 2689915
[TBL] [Abstract][Full Text] [Related]
20. Effects of dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure.
Riihioja P; Jaatinen P; Haapalinna A; Kiianmaa K; Hervonen A
Alcohol Clin Exp Res; 1999 Mar; 23(3):432-8. PubMed ID: 10195815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
